G6PD protects from oxidative damage and improves healthspan in mice

Nature Communications

Volumn 7, Issue , 2016, Pages

  Nóbrega Pereira, Sandrina ^a,b   Fernandez Marcos, Pablo J ^a,c   Brioche, Thomas ^d   Gomez Cabrera, Mari Carmen ^e   Salvador Pascual, Andrea ^e   Flores, Juana M ^f   Viña, Jose ^e   Serrano, Manuel ^a  

^a Centro Nacional de Investigations Oncológicas   (Spain)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c IMDEA FOOD INSTITUTE   (Spain)

^d UNIV MONTPELLIER   (France)

^e UNIVERSITY OF VALENCIA   (Spain)

^f UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE DISULFIDE; KRUPPEL LIKE FACTOR 4; MALONALDEHYDE; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; TRANSCRIPTION FACTOR SOX2; URIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

CELLS AND CELL COMPONENTS; DISEASE; ENZYME ACTIVITY; GENETIC ANALYSIS; OXIDATION; RODENT; TUMOR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENERGY EXPENDITURE; ENZYME ACTIVITY; FAT MASS; FEMALE; GENE OVEREXPRESSION; GENOMIC FRAGMENT; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESPAN; LIPID OXIDATION; MALE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN CARBONYLATION; URIC ACID BLOOD LEVEL; ANIMAL; GENETICS; HUMAN; LONGEVITY; METABOLISM; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

AGING; ANIMALS; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; LONGEVITY; MALE; MICE; MICE, TRANSGENIC; NADP; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84961156995     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10894     Document Type: Article

References (41)

1. DAutreaux, B. & Toledano, M. B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813-824 (2007).
2. Finkel, T. & Holbrook, N. J. Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247 (2000).
3. Harman, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300 (1956).
4. Hamilton, R. T., Walsh, M. E. & Van Remmen, H. Mouse models of oxidative stress indicate a role for modulating healthy aging. J. Clin. Exp. Pathol. S4, 005 (2012).
5. Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C. & Lillig, C. H. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid. Redox Signal. 19, 1539-1605 (2013).
6. Hillar, A. & Nicholls, P. A mechanism for NADPH inhibition of catalase compound II formation. FEBS Lett. 314, 179-182 (1992).
7. Cappellini, M. D. & Fiorelli, G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 371, 64-74 (2008).
8. Stanton, R. C. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64, 362-369 (2012).
9. Jeng, W., Loniewska, M. M. & Wells, P. G. Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice. ACS Chem Neurosci. 4, 1123-1132 (2013).
10. Kuehne, A., et al. Acute activation of oxidative pentose phosphate pathway as first-line response to oxidative stress in human skin cells. Mol. Cell 59, 359-371 (2015).
11. Legan, S. K., et al. Overexpression of glucose-6-phosphate dehydrogenase extends the life span of Drosophila melanogaster. J. Biol. Chem. 283, 32492-32499 (2008).
12. Corcoran, C. M., Fraser, P., Martini, G., Luzzatto, L. & Mason, P. J. High-level regulated expression of the human G6PD gene in transgenic mice. Gene 173, 241-246 (1996).
13. Manganelli, G., Masullo, U., Passarelli, S. & Filosa, S. Glucose-6-phosphate dehydrogenase deficiency: disadvantages and possible benefits. Cardiovasc. Hematol. Disord. Drug Targets 13, 73-82 (2013).
14. Ying, W. NAD/NADH and NADP/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal. 10, 179-206 (2008).
15. Williamson, D. H., Lund, P. & Krebs, H. A. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 103, 514-527 (1967).
16. Li, D., et al. A new G6PD knockdown tumor-cell line with reduced proliferation and increased susceptibility to oxidative stress. Cancer Biother. Radiopharm. 24, 81-90 (2009).
17. Kuo, W. Y. & Tang, T. K. Effects of G6PD overexpression in NIH3T3 cells treated with tert-butyl hydroperoxide or paraquat. Free Radic. Biol. Med. 24, 1130-1138 (1998).
18. Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006).
19. Wang, J., et al. Overexpression of G6PD is associated with poor clinical outcome in gastric cancer. Tumour Biol. 33, 95-101 (2012).
20. Zhang, C., Zhang, Z., Zhu, Y. & Qin, S. Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer. Anticancer Agents Med. Chem. 14, 280-289 (2014).
21. Jiang, P., et al. p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 13, 310-316 (2011).
22. Kuo, W., Lin, J. & Tang, T. K. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int. J. Cancer 85, 857-864 (2000).
23. Banito, A. & Gil, J. Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep. 11, 353-359 (2010).
24. Jacks, T., et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
25. Barlow, C., et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159-171 (1996).
26. Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell Biol. 12, 954-961 (1992).
27. Harris, A. W., et al. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167, 353-371 (1988).
28. Garcia-Cao, I., et al. Super p53 mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21, 6225-6235 (2002).
29. Matheu, A., et al. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 18, 2736-2746 (2004).
30. Sinitsyna, O., et al. Age-associated changes in oxidative damage and the activity of antioxidant enzymes in rats with inherited overgeneration of free radicals. J. Cell. Mol. Med. 10, 206-215 (2006).
31. Kasapoglu, M. & Ozben, T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp. Gerontol. 36, 209-220 (2001).
32. Ibim, S. E., Randall, R., Han, P. & Musey, P. I. Modulation of hepatic glucose-6-phosphate dehydrogenase activity in male and female rats by estrogen. Life Sci. 45, 1559-1565 (1989).
33. Sun, Y., et al. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells. Cell Death Dis. 5, e1231 (2014).
34. Ballatori, N., et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 390, 191-214 (2009).
35. Li, H., et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136-1139 (2009).
36. Waller, H. D., Lohr, G. W. & Tabatabai, M. Hemolysis and absence of glucose-6-phosphate dehydrogenase in erythrocytes; an enzyme abnormality of erythrocytes. Klin. Wochenschr. 35, 1022-1027 (1957).
37. Miwa, I., Fukatsu, H., Toyoda, Y. & Okuda, J. Anomeric preference of glucose utilization in human erythrocytes loaded with glucokinase. Biochem. Biophys. Res. Commun. 173, 201-207 (1990).
38. Brioche, T., et al. Growth hormone replacement therapy prevents sarcopenia by a dual mechanism: improvement of protein balance and of antioxidant defenses. J. Gerontol. A. Biol. Sci. Med. Sci. 69, 1186-1198 (2014).
39. Wong, S. H., et al. Lipoperoxides in plasma as measured by liquidchromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem. 33, 214-220 (1987).
40. Romagnoli, M., et al. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radic. Biol. Med. 49, 171-177 (2010).
41. Gomez-Cabrera, M.-C., et al. Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats. J. Physiol. 567, 113-120 (2005).